Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Ingram

Showing results (321-330 of 507) with videos related to

Pageof 51
Sort By:
Dermatology and Therapy|January 6, 2024
Burden of Hidradenitis Suppurativa: A Systematic Literature Review of Patient Reported OutcomesAlexa B Kimball, Joslyn Kirby, John R Ingram, et al.
The Journal of Antimicrobial Chemotherapy|November 2, 2017
Successful outpatient parenteral antibiotic therapy delivery via telemedicineShu J Tan, Paul R Ingram, Alison J Rothnie, et al.
The British Journal of Dermatology|July 10, 2019
Hidradenitis Suppurativa Area and Severity Index (HASI): a pilot study to develop a novel instrument to measure the physical signs of hidradenitis suppurativaN Goldfarb, J R Ingram, G B E Jemec, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 4, 2025
Hidradenitis suppurativa with and without draining tunnels: A real-world study characterizing differences in treatment and disease burdenJ R Ingram, A V Marzano, E Prens, et al.
The British Journal of Dermatology|June 30, 2020
Global Hidradenitis Suppurativa COVID-19 Registry: a registry to inform data-driven management practicesH B Naik, R Alhusayen, J Frew, et al.
The Patient|January 11, 2023
Patient Preferences in the Management of Hidradenitis Suppurativa: Results of a Multinational Discrete Choice Experiment in EuropeDamon Willems, Eva-Lotta Hinzpeter, Hessel H Van der Zee, et al.
The British Journal of Dermatology|November 10, 2019
The Hidradenitis Suppurativa Quality of Life (HiSQOL) score: development and validation of a measure for clinical trialsJ S Kirby, L Thorlacius, B Villumsen, et al.
Mycoses|August 4, 2022
Antifungal use via outpatient parenteral antimicrobial therapySu M Chew, Christopher H Heath, Cecilia Petursson, et al.
Journal of Medical Economics|March 23, 2023
A discrete-choice experiment to elicit the treatment preferences of patients with hidradenitis suppurativa in the United StatesD Willems, C J Sayed, H H Van der Zee, et al.
Journal of Cutaneous Pathology|May 31, 2017
Index report of cutaneous angiosarcomas with strong positivity for tyrosinase mimicking melanoma with further evaluation of melanocytic markers in a large angiosarcoma seriesAlicia Leon-Castillo, John S A Chrisinger, Gauri Panse, et al.
Pageof 51

Showing results (321-330 of 507) with videos related to

Sort By:
Pageof 51
Dermatology and Therapy|January 6, 2024
Burden of Hidradenitis Suppurativa: A Systematic Literature Review of Patient Reported OutcomesAlexa B Kimball, Joslyn Kirby, John R Ingram, et al.
The Journal of Antimicrobial Chemotherapy|November 2, 2017
Successful outpatient parenteral antibiotic therapy delivery via telemedicineShu J Tan, Paul R Ingram, Alison J Rothnie, et al.
The British Journal of Dermatology|July 10, 2019
Hidradenitis Suppurativa Area and Severity Index (HASI): a pilot study to develop a novel instrument to measure the physical signs of hidradenitis suppurativaN Goldfarb, J R Ingram, G B E Jemec, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 4, 2025
Hidradenitis suppurativa with and without draining tunnels: A real-world study characterizing differences in treatment and disease burdenJ R Ingram, A V Marzano, E Prens, et al.
The British Journal of Dermatology|June 30, 2020
Global Hidradenitis Suppurativa COVID-19 Registry: a registry to inform data-driven management practicesH B Naik, R Alhusayen, J Frew, et al.
The Patient|January 11, 2023
Patient Preferences in the Management of Hidradenitis Suppurativa: Results of a Multinational Discrete Choice Experiment in EuropeDamon Willems, Eva-Lotta Hinzpeter, Hessel H Van der Zee, et al.
The British Journal of Dermatology|November 10, 2019
The Hidradenitis Suppurativa Quality of Life (HiSQOL) score: development and validation of a measure for clinical trialsJ S Kirby, L Thorlacius, B Villumsen, et al.
Mycoses|August 4, 2022
Antifungal use via outpatient parenteral antimicrobial therapySu M Chew, Christopher H Heath, Cecilia Petursson, et al.
Journal of Medical Economics|March 23, 2023
A discrete-choice experiment to elicit the treatment preferences of patients with hidradenitis suppurativa in the United StatesD Willems, C J Sayed, H H Van der Zee, et al.
Journal of Cutaneous Pathology|May 31, 2017
Index report of cutaneous angiosarcomas with strong positivity for tyrosinase mimicking melanoma with further evaluation of melanocytic markers in a large angiosarcoma seriesAlicia Leon-Castillo, John S A Chrisinger, Gauri Panse, et al.
Pageof 51